Page last updated: 2024-08-17

physostigmine and Nervous System Disorders

physostigmine has been researched along with Nervous System Disorders in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19909 (75.00)18.7374
1990's3 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SOROKHTIN, GN1
COHEN, A; GOLDMAN, J; TROMMER, P1
Edge, PC; Grell, GA; Melville, GN; Wray, SR1
Cooper, GH; Gordon, JJ; Inns, RH; Johnson, MK; Leadbeater, L; Maidment, MP; Rickard, RL; Upshall, DG1
Irwin, HA; Preskorn, SH1
Fukushima, M; Horiguchi, H; Konno, N; Suzuki, N1
Keesey, JC1
Goldbarg, A; Klawans, HL; Kramer, J; Weisdorf, D1
Dworacek, B; Rupreht, J1
Baldessarini, RJ; Granacher, RP1
Adams, N; Corcoran, K; Kaminskis, A; Maitland, G; von Bredow, J; Wade, J1
Campbell, GA; Davis, KL; Haroutunian, V; Kanof, PD; Tsuboyama, GK1

Reviews

1 review(s) available for physostigmine and Nervous System Disorders

ArticleYear
Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
    The West Indian medical journal, 1981, Volume: 30, Issue:3

    Topics: Amphetamine; Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Brain; Cholinesterase Inhibitors; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Huntington Disease; Hyperkinesis; Models, Neurological; Movement Disorders; Nervous System Diseases; Neurotransmitter Agents; Parkinson Disease; Physostigmine; Rats

1981

Other Studies

11 other study(ies) available for physostigmine and Nervous System Disorders

ArticleYear
[Theory of eserine therapy in organic diseases of the central nervous system].
    Nevropatologiia i psikhiatriia, 1946, Volume: 15, Issue:1

    Topics: Central Nervous System; Nervous System Diseases; Physostigmine

1946
Physostigmine for muscle spasm in rheumatoid arthritis.
    Journal of the American Medical Association, 1946, Feb-02, Volume: 130

    Topics: Arthritis; Arthritis, Rheumatoid; Humans; Nervous System Diseases; Physostigmine; Spasm

1946
The delayed neuropathic effects of nerve agents and some other organophosphorus compounds.
    Archives of toxicology, 1983, Volume: 52, Issue:2

    Topics: Acetylcholinesterase; Animals; Atropine; Brain; Carboxylic Ester Hydrolases; Chemical Warfare; Chickens; Cholinesterase Inhibitors; Isoflurophate; Lethal Dose 50; Nervous System Diseases; Organophosphorus Compounds; Physostigmine

1983
Toxicity of tricyclic antidepressants--kinetics, mechanism, intervention: a review.
    The Journal of clinical psychiatry, 1982, Volume: 43, Issue:4

    Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Child; Dose-Response Relationship, Drug; Humans; Lidocaine; Metabolic Clearance Rate; Myocardial Contraction; Nervous System Diseases; Physostigmine; Propranolol; Risk

1982
Characterization of high-affinity binding sites for diisopropylfluorophosphate (DFP) from chicken spinal cord membranes.
    Biochemical pharmacology, 1994, Nov-29, Volume: 48, Issue:11

    Topics: Animals; Binding Sites; Chickens; Chromatography, Gel; Isoflurophate; Nervous System Diseases; Physostigmine; Spinal Cord; Tritolyl Phosphates

1994
Contemporary opinions about Mary Walker: a shy pioneer of therapeutic neurology.
    Neurology, 1998, Volume: 51, Issue:5

    Topics: Cholinesterase Inhibitors; History, 19th Century; History, 20th Century; Humans; Myasthenia Gravis; Neostigmine; Nervous System Diseases; Neurology; Physostigmine

1998
Physostigmine for cardiac and neurologic manifestations of phenothiazine poisoning.
    Clinical pharmacology and therapeutics, 1978, Volume: 24, Issue:6

    Topics: Antipsychotic Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Male; Middle Aged; Nervous System Diseases; Parasympatholytics; Physostigmine; Trifluoperazine

1978
Central anticholinergic syndrome in anesthetic practice.
    Acta anaesthesiologica Belgica, 1976, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Aged; Anesthesia; Central Nervous System Diseases; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Nervous System Diseases; Parasympathetic Nervous System; Parasympatholytics; Physostigmine; Synapses

1976
Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.
    Archives of general psychiatry, 1975, Volume: 32, Issue:3

    Topics: Acute Disease; Adult; Amitriptyline; Benztropine; Chemical Phenomena; Chemistry; Cholinesterase Inhibitors; Doxepin; Female; Haloperidol; Humans; Male; Nervous System Diseases; Parasympatholytics; Physostigmine; Psychoses, Substance-Induced; Syndrome; Thioridazine

1975
Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1991, Volume: 17, Issue:4

    Topics: Animals; Cholinesterases; Erythrocytes; Female; Lethal Dose 50; Macaca fascicularis; Male; Nervous System Diseases; Parasympatholytics; Physostigmine; Scopolamine; Soman; Trihexyphenidyl

1991
Animal models of Alzheimer's disease: behavior, pharmacology, transplants.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1986, Volume: 13, Issue:4 Suppl

    Topics: 4-Aminopyridine; Alzheimer Disease; Aminopyridines; Animals; Behavior, Animal; Brain; Disease Models, Animal; Fetus; Growth Substances; Humans; Nerve Growth Factors; Nerve Tissue; Nerve Tissue Proteins; Nervous System Diseases; Norepinephrine; Parasympathetic Nervous System; Physostigmine; Somatostatin

1986